COVID-19大流行对非PCI能力三级医院STEMI溶栓及急诊科绩效的影响
该单中心回顾性研究连续纳入2019年5月至2020年12月(20个月)在非PCI能力三级医院接受溶栓治疗的STEMI患者,比较大流行前10个月与大流行期间10个月的患者特征与结局。共分析323例患者,平均年龄52.9±12.9岁,男性280例(88.9%)。大流行期间溶栓量减少12.5%,症状发作至溶栓时间及门-针时间无显著差异;院内死亡率显著升高(OR 2.02,95%CI 1.02-4.00,p=0.044)。溶栓后出血事件保持稳定,过夜留观数无显著差异。
要点
- 大流行期间STEMI溶栓量减少12.5%,但症状发作至溶栓时间和门-针时间无显著差异。
- 大流行期间院内死亡率显著升高(OR 2.02,95%CI 1.02-4.00,p=0.044)。
- 溶栓后出血事件保持稳定,过夜留观数无显著差异。
- 研究纳入323例接受溶栓的STEMI患者,平均年龄52.9±12.9岁,男性280例(88.9%)。
适用人群与场景
- 2019年5月至2020年12月(20个月)在非PCI能力三级医院连续接受溶栓治疗的STEMI患者,共323例,平均年龄52.9±12.9岁,男性280例(88.9%)。
研究设计与关键结果
- 单中心回顾性研究,采用全人群抽样,连续纳入2019年5月至2020年12月(20个月)在非PCI能力三级医院接受溶栓治疗的STEMI患者,比较大流行前10个月与大流行期间10个月。
- 共分析323例患者,平均年龄52.9±12.9岁,男性280例(88.9%)。
- 大流行期间溶栓量减少12.5%。
- 症状发作至溶栓时间及门-针时间无显著差异。
- 院内死亡率在大流行期间显著升高(OR 2.02,95%CI 1.02-4.00,p=0.044)。
- 溶栓后出血事件保持稳定,过夜留观数无显著差异。
证据类型、等级与局限
- 证据类型:单中心回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在非PCI能力中心,大流行期间即使门-针时间保持,STEMI溶栓患者的院内死亡风险仍升高(OR 2.02,95%CI 1.02-4.00,p=0.044);溶栓量减少12.5%。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Some guidelines had recommended "thrombolysis first" in ST-elevated myocardial infarction (STEMI) during the Coronavirus Disease 2019 (COVID-19) outbreak. The impact of COVID-19 solely on STEMI thrombolysis is lacking as most studies reported outcomes related to percutaneous coronary intervention (PCI) setting. Thus, this study aimed to assess the impact of the COVID-19 pandemic on STEMI thrombolysis outcomes and the Emergency Department's performance in a non-PCI capable centre.
METHODS: This single-centre retrospective study analysed data on consecutive STEMI patients who received thrombolytic therapy from May 2019 to December 2020 (20 months) in a non-PCI capable tertiary hospital. Total population sampling was used in this study. We compared all patients' characteristics and outcomes ten months before and during the pandemic. Regression models were used to assess the impact of COVID-19 pandemic on door-to-needle time (DNT), mortality, bleeding events, and the number of overnight stays.
RESULTS AND DISCUSSION: We analysed 323 patients with a mean age of 52.9 ± 12.9 years and were predominantly male (n = 280, 88.9%). There was a 12.5% reduction in thrombolysis performed during the pandemic. No significant difference in timing from symptoms onset to thrombolysis and DNT was observed. In-hospital mortality was significantly higher during the pandemic (OR 2.02, 95% CI 1.02-4.00, p = 0.044). Bleeding events post thrombolysis remained stable and there was no significant difference in the number of overnight stays during the pandemic.
CONCLUSION: STEMI thrombolysis cases were reduced during the COVID-19 pandemic, with an inverse increase in mortality despite the preserved Emergency Department performance in timely thrombolysis.
参考来源
- Koh HP, Md Redzuan A, Mohd Saffian S, et al. Impact of COVID-19 pandemic on STEMI thrombolysis and Emergency Department's performance in a non-PCI capable tertiary hospital. Am J Emerg Med. 2022. PMID: 35872375. doi:10.1016/j.ajem.2022.07.021
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。